Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker Baddour et al Infective Endocarditis in Adults 1481 lead endocarditis clinical profiles. Heart. 2005;91:e10. doi: 10.1136/ hrt.2004.040659. 144. Liu PY, Huang YF, Tang CW, Chen YY, Hsieh KS, Ger LP, Chen YS, Liu YC. Staphylococcus lugdunensis infective endocarditis: a litera- ture review and analysis of risk factors. J Microbiol Immunol Infect. 2010;43:478 484. doi: 10.1016/S1684-1182(10)60074-6. 145. Seenivasan MH, Yu VL. Staphylococcus lugdunensis endocarditis: the hidden peril of coagulase-negative staphylococcus in blood cul- tures. Eur J Clin Microbiol Infect Dis. 2003;22:489 491. doi: 10.1007/ s10096-003-0953-z. 146. Pereira EM, Oliveira FL, Schuenck RP, Zoletti GO, Dos Santos KR. Detection of Staphylococcus lugdunensis by a new species-specific PCR based on the fbl gene. FEMS Immunol Med Microbiol. 2010;58:295 298. doi: 10.1111/j.1574-695X.2009.00626.x. 147. Pinsky BA, Samson D, Ghafghaichi L, Baron EJ, Banaei N. Comparison of real-time PCR and conventional biochemical methods for identifica- tion of Staphylococcus lugdunensis. J Clin Microbiol. 2009;47:3472 3477. doi: 10.1128/JCM.00342-09. 148. Fort n J, Navas E, Mart nez-Beltr n J, P rez-Molina J, Mart n-D vila P, Guerrero A, Moreno S. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glyco- peptides in combination with gentamicin. Clin Infect Dis. 2001;33:120 125. doi: 10.1086/320869. 149. Cosgrove SE, Vigliani GA, Fowler VG Jr, Abrutyn E, Corey GR, Levine DP, Rupp ME, Chambers HF, Karchmer AW, Boucher HW. Initial low- dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis. 2009;48:713 721. doi: 10.1086/597031. 150. 